Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    A091102
Previous Study | Return to List | Next Study

Alisertib in Treating Patients With Advanced or Metastatic Sarcoma

This study has suspended participant recruitment.
(Temporarily stopped for assessment.)
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT01653028
First received: July 26, 2012
Last updated: February 2, 2016
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: No date given
  Primary Completion Date: February 2016 (Final data collection date for primary outcome measure)